Figure 19.1 Challenging thrombosis scenarios. MPN, myeloproliferative neoplasm; APC, activated protein C resistance. As reviewed in: Falanga A, Marchetti M. Thrombosis in myeloproliferative neoplasms. Semin Thromb Hemost. 2014;40(3):348–58. Adapted from:…
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> 18 Managing acute vascular events in patients with myeloproliferative neoplasms David A. Garcia and Bethany T. Samuelson Case 1 A 62-year-old man is referred to hematology…
Figure 17.1 Local management protocol. FBC, full blood count; BP, blood pressure; PV, polycythemia vera. There are no controlled studies regarding pregnancy outcome. As such there are no validated predictors…
+8, –7/7q–, –5/5q–, i17q, 12p–, 11q23 rearr.+1 point each1 point each (Hb: 2 points)DIPSS int-1: 1 pointDIPSS int-2: 2 pointsDIPPS high: 3 pointsPlatelets < 100 × 109/L, unfavorable karyotype, transfusion…
Figure 13.1 Diagnostic algorithm for hypereosinophilia and treatment options based on each subtype. FISH, fluorescent in situ hybridization; RT-PCR, reverse transcriptase polymerase chain reaction; NOS, not otherwise specified; WHO, World…
1 is most favorable and 10 least favorablePlease rate your fatigue (weariness, tiredness) by circling the one number that best describes your worst level of fatigue during past 24 hoursa(No…
Manage scenarios associated with increased risk, e.g., surgery, pregnancy The most important direct way of assessing compliance is through patient interview.2 Other measures, such as direct observation of medication intake,…
Figure 7.1 Flow chart of recommendations for the management of patients with essential thrombocythemia (ET). CV, cardiovascular; HU, hydroxyurea; WHO, World Health Organization. Intervention on lifestyle Thrombosis is a multifactorial…
(pending WHO endorsement) Major criteria1. Hb >18.5 g/dL in men, >16.5 g/dL in women, or evidence of increased red cell volume, ora1. Hb >16.5 g/dL in men, > 16.0 g/dL…
